๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Blockade of IGF-IR function reduces COX-2 expression in human pancreatic cancer cells

โœ Scribed by O. Stoeltzing; F. Fan; W. Liu; A. A. Parikh; N. Reinmuth; D. J. Hicklin; L. M. Ellis

Book ID
110547728
Publisher
Springer
Year
2004
Tongue
English
Weight
278 KB
Volume
11
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Enhanced expression of cyclooxygenase (C
Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression
โœ Yuko Higashi; Takuro Kanekura; Tamotsu Kanzaki ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 129 KB ๐Ÿ‘ 2 views

Cyclooxygenase (COX)-2 is one of the rate-limiting enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. Recent studies have shown enhanced expression of COX-2 in cancer cells of several tissues. We investigated the expression of COX-2 and prostaglandin (PG) E 2 prod

Serial in vivo loss and in vitro gain of
Serial in vivo loss and in vitro gain of Fas expression and function in human cancerous pancreatic duct cells
โœ Soroosh Radfar; Christian Davrinche; Etienne Hollande ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 512 KB

## Abstract Recent studies have shown the involvement of the Fas system (Fas receptor and its ligand FasL) in cancerous processes. The absence or downregulation of Fas, reported in the majority of human tumors, conflicts with its presence in cancerous cells from the same tumors but maintained __in